Showing 8 posts of 8 posts found.

Targeted chemotherapy to kill all solid tumours developed in preclinical research

August 3, 2023
Research and Development Cancer, Oncology, chemotherapy, pharmaceutical, tumour

Researchers from the City of Hope organisation in the US have released a study confirming the development of AOH1996, a …

Bowel cancers adjust themselves to hide from immunotherapies

April 15, 2019
Sales and Marketing CEA, Cancer, bowel cancer, immunotherapy, oncology, tumour

Bowel cancers can avoid being caught by immunotherapy by ‘switching off’ a molecule on the surface of cells that is …

Tumours with large number of mutations respond better to immunotherapies, study shows

January 15, 2019
Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour

Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …

New ‘pen’ device identifies cancerous tissue in just ten seconds

September 7, 2017
Research and Development Cancer, University of Texas, digital, medicine, pharma, pharmaceutical, tumour

Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …


Antiparasitic drug repurposed for treatment of brain tumours

April 13, 2017
Research and Development Low-grade glioma, parasitic pinworms, tumour

Researchers from The Feinstein Institute for Medical Research’s Karches Center for Oncology Research has had a research breakthrough by taking …


Foundation Medicine adds new immunotherapy features to its gene profiling products

August 23, 2016
Manufacturing and Production, Research and Development FoundationOne, oncology, tumour

Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …


Darzalex to be trialled in combination with atezolizumab in multiple myeloma and solid tumours

March 22, 2016
Research and Development Genentech, Genmab, Janssen, Roche, atezolizumab, clnical trials, multiple myeloma, phase ib, solid tumours, tumour

Phase Ib clinical studies are set to begin, which will evaluate Darzalex (daratumumab) in combination with atezolizumab in a solid …

Eisai image

Eisai cancer drug performs in sarcoma disease

February 26, 2015
Sales and Marketing Cancer, Eisai, Halaven, eribulin, sarcoma, tumour

Eisai’s cancer drug Halaven met its primary endpoint and demonstrated overall survival benefit in two distinct solid tumour types in …

Latest content